Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Free Cash Flow per Share of $-58.59 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-8.96M |
|
-- |
|
-- |
|
$9.53M |
|
$-9.53M |
|
$0.57M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-8.96M |
|
$-9.53M |
|
$-9.43M |
|
0.13M |
|
0.13M |
|
$-66.78 |
|
$-66.78 |
|
| Balance Sheet Financials | |
$14.93M |
|
-- |
|
$0.78M |
|
$15.71M |
|
$4.18M |
|
-- |
|
$2.32M |
|
$6.50M |
|
$9.20M |
|
$8.72M |
|
$9.20M |
|
0.26M |
|
| Cash Flow Statement Financials | |
$-7.86M |
|
$-1.89M |
|
$10.97M |
|
$2.40M |
|
$3.62M |
|
$1.22M |
|
$1.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-97.37% |
|
-102.76% |
|
-57.05% |
|
-97.37% |
|
$35.97 |
|
|
Free Cash Flow per Share |
$-58.59 |
$-58.59 |
|